302 related articles for article (PubMed ID: 27766559)
1. Survival Outcome and Risk of Metachronous Colorectal Cancer After Surgery in Lynch Syndrome.
Kim TJ; Kim ER; Hong SN; Kim YH; Huh JW; Park YA; Cho YB; Yun SH; Kim HC; Lee WY; Kim K; Kim K; Chang DK
Ann Surg Oncol; 2017 Apr; 24(4):1085-1092. PubMed ID: 27766559
[TBL] [Abstract][Full Text] [Related]
2. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery.
Parry S; Win AK; Parry B; Macrae FA; Gurrin LC; Church JM; Baron JA; Giles GG; Leggett BA; Winship I; Lipton L; Young GP; Young JP; Lodge CJ; Southey MC; Newcomb PA; Le Marchand L; Haile RW; Lindor NM; Gallinger S; Hopper JL; Jenkins MA
Gut; 2011 Jul; 60(7):950-7. PubMed ID: 21193451
[TBL] [Abstract][Full Text] [Related]
3. Metachronous serrated neoplasia is uncommon after right colectomy in patients with methylator colon cancers with a high degree of microsatellite instability.
Messick CA; Kravochuck S; Church JM; Kalady MF
Dis Colon Rectum; 2014 Jan; 57(1):39-46. PubMed ID: 24316944
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of Segmental Colectomy Followed by Endoscopic Surveillance as a Treatment Strategy for Colorectal Cancer Patients with Lynch Syndrome.
Nagasaki T; Arai M; Chino A; Akiyoshi T; Fukunaga Y; Ueno M
Dig Surg; 2018; 35(5):448-456. PubMed ID: 29017165
[TBL] [Abstract][Full Text] [Related]
5. Risk of Metachronous Colorectal Neoplasm after a Segmental Colectomy in Lynch Syndrome Patients According to Mismatch Repair Gene Status.
Quezada-Diaz FF; Hameed I; von Mueffling A; Salo-Mullen EE; Catalano A; Smith JJ; Weiser MR; Garcia-Aguilar J; Stadler ZK; Guillem JG
J Am Coll Surg; 2020 Apr; 230(4):669-675. PubMed ID: 32007537
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of proximal colectomy for surgical management of right-sided first colorectal cancer in Lynch Syndrome mutation carriers.
Hiatt MJ; Casey MJ; Lynch HT; Snyder CL; Stacey M; Walters RW
Am J Surg; 2018 Jul; 216(1):99-105. PubMed ID: 29153248
[TBL] [Abstract][Full Text] [Related]
7. DNA Mismatch Repair Status Predicts Need for Future Colorectal Surgery for Metachronous Neoplasms in Young Individuals Undergoing Colorectal Cancer Resection.
Aronson M; Holter S; Semotiuk K; Winter L; Pollett A; Gallinger S; Cohen Z; Gryfe R
Dis Colon Rectum; 2015 Jul; 58(7):645-52. PubMed ID: 26200678
[TBL] [Abstract][Full Text] [Related]
8. Metachronous colorectal carcinoma with massive submucosal invasion detected by annual surveillance in a Lynch syndrome patient: a case report.
Utsumi M; Tanakaya K; Mushiake Y; Kunitomo T; Yasuhara I; Taniguchi F; Arata T; Katsuda K; Aoki H; Takeuchi H
World J Surg Oncol; 2017 Aug; 15(1):140. PubMed ID: 28764791
[TBL] [Abstract][Full Text] [Related]
9. Subtotal Colectomy for Colon Cancer Reduces the Need for Subsequent Surgery in Lynch Syndrome.
Renkonen-Sinisalo L; Seppälä TT; Järvinen HJ; Mecklin JP
Dis Colon Rectum; 2017 Aug; 60(8):792-799. PubMed ID: 28682964
[TBL] [Abstract][Full Text] [Related]
10. Metachronous colorectal cancer following segmental or extended colectomy in Lynch syndrome: a systematic review and meta-analysis.
Malik SS; Lythgoe MP; McPhail M; Monahan KJ
Fam Cancer; 2018 Oct; 17(4):557-564. PubMed ID: 29189962
[TBL] [Abstract][Full Text] [Related]
11. Colorectal surveillance after segmental resection for young-onset colorectal cancer: is there evidence for extended resection?
Kozak VN; Kalady MF; Gamaleldin MM; Liang J; Church JM
Colorectal Dis; 2017 Nov; 19(11):O386-O392. PubMed ID: 28865167
[TBL] [Abstract][Full Text] [Related]
12. High risk of rectal cancer and of metachronous colorectal cancer in probands of families fulfilling the Amsterdam criteria.
Cirillo L; Urso ED; Parrinello G; Pucciarelli S; Moneghini D; Agostini M; Nitti D; Nascimbeni R
Ann Surg; 2013 May; 257(5):900-4. PubMed ID: 22968081
[TBL] [Abstract][Full Text] [Related]
13. Risk of metachronous colorectal cancer following colectomy in Lynch syndrome: a systematic review and meta-analysis.
Anele CC; Adegbola SO; Askari A; Rajendran A; Clark SK; Latchford A; Faiz OD
Colorectal Dis; 2017 Jun; 19(6):528-536. PubMed ID: 28407411
[TBL] [Abstract][Full Text] [Related]
14. Metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after extensive versus partial colectomy in the Netherlands: a retrospective cohort study.
Eikenboom EL; Moen S; van Leerdam ME; Papageorgiou G; Doukas M; Tanis PJ; Dekker E; Wagner A; Spaander MCW;
Lancet Gastroenterol Hepatol; 2023 Dec; 8(12):1106-1117. PubMed ID: 37865103
[TBL] [Abstract][Full Text] [Related]
15. Patterns of surgery in patients belonging to amsterdam-positive families.
Van Dalen R; Church J; McGannon E; Fay S; Burke C; Clark B
Dis Colon Rectum; 2003 May; 46(5):617-20. PubMed ID: 12792437
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for metachronous colorectal cancer in Lynch syndrome patients: a registry-based observational mono-institutional study cohort.
Signoroni S; Piozzi GN; Ricci MT; Mancini A; Morabito A; Bertario L; Vitellaro M
Int J Clin Oncol; 2020 Sep; 25(9):1644-1652. PubMed ID: 32430733
[TBL] [Abstract][Full Text] [Related]
17. Risk of colorectal adenoma and carcinoma after colectomy for colorectal cancer in patients meeting Amsterdam criteria.
Kalady MF; McGannon E; Vogel JD; Manilich E; Fazio VW; Church JM
Ann Surg; 2010 Sep; 252(3):507-11; discussion 511-3. PubMed ID: 20739851
[TBL] [Abstract][Full Text] [Related]
18. One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.
Vasen HF; Abdirahman M; Brohet R; Langers AM; Kleibeuker JH; van Kouwen M; Koornstra JJ; Boot H; Cats A; Dekker E; Sanduleanu S; Poley JW; Hardwick JC; de Vos Tot Nederveen Cappel WH; van der Meulen-de Jong AE; Tan TG; Jacobs MA; Mohamed FL; de Boer SY; van de Meeberg PC; Verhulst ML; Salemans JM; van Bentem N; Westerveld BD; Vecht J; Nagengast FM
Gastroenterology; 2010 Jun; 138(7):2300-6. PubMed ID: 20206180
[TBL] [Abstract][Full Text] [Related]
19. Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database.
Møller P; Seppälä T; Bernstein I; Holinski-Feder E; Sala P; Evans DG; Lindblom A; Macrae F; Blanco I; Sijmons R; Jeffries J; Vasen H; Burn J; Nakken S; Hovig E; Rødland EA; Tharmaratnam K; de Vos Tot Nederveen Cappel WH; Hill J; Wijnen J; Green K; Lalloo F; Sunde L; Mints M; Bertario L; Pineda M; Navarro M; Morak M; Renkonen-Sinisalo L; Frayling IM; Plazzer JP; Pylvanainen K; Sampson JR; Capella G; Mecklin JP; Möslein G;
Gut; 2017 Mar; 66(3):464-472. PubMed ID: 26657901
[TBL] [Abstract][Full Text] [Related]
20. Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members.
Järvinen HJ; Renkonen-Sinisalo L; Aktán-Collán K; Peltomäki P; Aaltonen LA; Mecklin JP
J Clin Oncol; 2009 Oct; 27(28):4793-7. PubMed ID: 19720893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
